Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| REPLIGEN CORPRGEN · Entity 486 | Director | March 01, 2022 | March 03, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
REPLIGEN CORP
Report date March 01, 2022 · Filed March 03, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,457 |
Reported balance
After 2022-03-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-03-01 · Exercise / conversion · Acquired 1,000 · Balance 3,457 F1: The total reported in Column 5 has been adjusted to correct an overstatement of total holdings by 9,880 shares, first reflected in a Form 4 filed on November 2, 2021. |
| Common StockSEC Table I · non-derivative | Direct | 2,457 |
Reported balance
After 2022-03-01 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2022-03-01 · Sale · Disposed 1,000 · Balance 2,457 F2: $198.48 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.19 to $198.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| Common StockSEC Table I · non-derivative | Direct | 1,457 |
Reported balance
After 2022-03-01 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2022-03-01 · Sale · Disposed 1,000 · Balance 1,457 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.76 · Expires 2030-11-11 | Direct | 0 |
Reported balance
After 2022-03-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-03-01 · Exercise / conversion · Acquired 1,000 · Balance 0 F3: This option is currently exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: The total reported in Column 5 has been adjusted to correct an overstatement of total holdings by 9,880 shares, first reflected in a Form 4 filed on November 2, 2021.
F2: $198.48 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.19 to $198.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3: This option is currently exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 29, 2017 Filed Mar 31, 2017 17:37 UTC | REPLIGEN CORP RGEN · Entity 486 | GiftCommon Stock | 350 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-014158 · doc1.xml · nonDerivative · entry 2 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,494 Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 17:37 UTC | REPLIGEN CORP RGEN · Entity 486 | GiftCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-014158 · doc1.xml · nonDerivative · entry 1 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,844 Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 20:34 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0001140361-17-012938 · doc1.xml · derivative · entry 3 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 4,000 shares Expires 2021-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is currently exercisable. Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 20:34 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 4,000 | $34.83 | $139,321.20 |
DisclosureSEC source: 0001140361-17-012938 · doc1.xml · nonDerivative · entry 2 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,594 F1 · price: $34.8303 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.64 to $35.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 20:34 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionCommon Stock | 4,000 | $3.22 | $12,880.00 |
DisclosureSEC source: 0001140361-17-012938 · doc1.xml · nonDerivative · entry 1 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,594 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 17:20 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 2,700 | $32.58 | $87,978.69 |
DisclosureSEC source: 0001140361-16-080002 · doc1.xml · nonDerivative · entry 1 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,394 Read SEC document |
| August 24, 2016 Filed Feb 15, 2017 00:48 UTC | REPLIGEN CORP RGEN · Entity 486 | GiftCommon Stock | 800 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-004088 · doc5.xml · nonDerivative · entry 1 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,594 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.